Exro Technologies Inc.
Exro Technologies Inc. (EXRO.TO) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Exro Technologies Inc. (EXRO.TO), covering cash flow, earnings, and balance sheets.
Exro Technologies Inc. (EXRO.TO) Income Statement & Financial Overview
Explore comprehensive income reports for Exro Technologies Inc. EXRO.TO, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $4.44M | $5.56M | $10.98M | $5.27M |
Cost of Revenue | $6.70M | $4.46M | $13.24M | $8.03M |
Gross Profit | -$2.26M | $1.11M | -$2.26M | -$2.76M |
Gross Profit Ratio | -$0.51 | $0.20 | -$0.21 | -$0.52 |
R&D Expenses | $1.30M | $925970.00 | $1.27M | $3.11M |
SG&A Expenses | $9.71M | $15.08M | $12.27M | $14.97M |
Operating Expenses | $18.40M | $61.96M | -$2.26M | $18.08M |
Total Costs & Expenses | $25.10M | $66.41M | $37.87M | $26.12M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $3.78M | $3.75M | $3.24M | $774325.00 |
Depreciation & Amortization | $7.39M | $7.34M | $11.20M | $10.98M |
EBITDA | -$12.37M | -$26.22M | -$223.48M | -$14.29M |
EBITDA Ratio | -$2.79 | -$4.71 | -$20.36 | -$2.71 |
Operating Income | -$20.66M | -$60.85M | $0.00 | -$20.85M |
Operating Income Ratio | -$4.65 | -$10.93 | $0.00 | -$3.96 |
Other Income/Expenses (Net) | -$2.88M | $25.94M | -$237.91M | -$5.07M |
Income Before Tax | -$23.54M | -$35.82M | -$237.91M | -$25.91M |
Income Before Tax Ratio | -$5.30 | -$6.44 | -$21.68 | -$4.92 |
Income Tax Expense | $0.00 | -$12.21M | -$12.09M | -$635537.00 |
Net Income | -$23.54M | -$24.91M | -$225.95M | -$25.21M |
Net Income Ratio | -$5.30 | -$4.48 | -$20.59 | -$4.78 |
EPS | -$0.04 | -$0.09 | -$0.43 | -$0.05 |
Diluted EPS | -$0.05 | -$0.09 | -$0.43 | -$0.05 |
Weighted Avg Shares Outstanding | $444.12M | $444.12M | $524.53M | $490.16M |
Weighted Avg Shares Outstanding (Diluted) | $444.12M | $444.12M | $524.53M | $490.16M |
Over the past four quarters, Exro Technologies Inc. demonstrated steady revenue growth, increasing from $5.27M in Q2 2024 to $4.44M in Q1 2025. Operating income reached -$20.66M in Q1 2025, maintaining a consistent -465% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$12.37M, reflecting operational efficiency. Net income rose to -$23.54M, with EPS at -$0.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan